RECURSION PHARMACEUTICALS IN
RXRX·75629V104·US·Common Stock·Healthcare - Biotechnology-Activist
RXRX (RECURSION PHARMACEUTICALS IN) is held by 159 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($132.6M), ARK Investment Management LLC ($123.5M), STATE STREET CORP ($87.5M). Net institutional sentiment: Mixed.
159
Holders
(32 Elite)
$909.8M
Total Value
59% (164)
Consensus
97 buying - 67 selling
13F: Insider & Congress:
Who's Trading
InsiderBBBorgeson BlakeSell $159KJul 7, 2026
InsiderKNKhan NajatSell $84KJun 5, 2026
InsiderGCGibson ChristopherSell $145KJun 5, 2026
InsiderBNBumpus NamandjeSell $16KJun 3, 2026
InsiderBBBorgeson BlakeSell $110KJun 2, 2026
InsiderGCGibson ChristopherC 60K shMay 7, 2026
InsiderGCGibson ChristopherSell $135KMay 7, 2026
InsiderGCGibson ChristopherGift 20K shMay 7, 2026
Showing 1-20 of 171
1 / 9
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer